BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 3933747)

  • 41. Bromocriptine treatment of postoperative prolactinoma patients.
    Yang DY; Wang YC
    Zhonghua Yi Xue Za Zhi (Taipei); 1994 Jun; 53(6):346-50. PubMed ID: 8087709
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Pregnancy in hyperprolactinemic patients].
    Ventz M; Puhlmann B; Knappe G; Gerl H; Lehmann R; Rohde W
    Zentralbl Gynakol; 1996; 118(11):610-5. PubMed ID: 9082694
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Management of prolactinomas during pregnancy].
    Chen W; Bian X; Gai M; Zhang Y
    Zhonghua Fu Chan Ke Za Zhi; 2002 Jun; 37(6):335-7. PubMed ID: 12126566
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Prolactinoma of the pituitary containing amyloid.
    Paetau A; Partanen S; Mustajoki P; Valtonen S; Pelkonen R; Wahlström T
    Acta Endocrinol (Copenh); 1985 Jun; 109(2):176-80. PubMed ID: 3893008
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prolactin secretion in patients with chromophobe adenomas of the pituitary: incidence and presentation of hyperprolactinaemia: results of surgical treatment.
    Franks S; Nabarro JD
    Ann Clin Res; 1978; 10(3):157-63. PubMed ID: 718118
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Current treatment issues in female hyperprolactinaemia.
    Crosignani PG
    Eur J Obstet Gynecol Reprod Biol; 2006 Apr; 125(2):152-64. PubMed ID: 16288952
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Psychological distress in patients with hyperprolactinaemia.
    Reavley A; Fisher AD; Owen D; Creed FH; Davis JR
    Clin Endocrinol (Oxf); 1997 Sep; 47(3):343-8. PubMed ID: 9373457
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Spontaneous development of hyperprolactinaemia.
    Rjosk HK; Fahlbusch R; von Werder K
    Acta Endocrinol (Copenh); 1982 Jul; 100(3):333-6. PubMed ID: 7113601
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Recurrent plurihormonal bimorphous pituitary adenoma producing growth hormone, thyrotropin, and prolactin.
    Felix I; Asa SL; Kovacs K; Horvath E; Smyth HS
    Arch Pathol Lab Med; 1994 Jan; 118(1):66-70. PubMed ID: 8285835
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Contribution to the problem of hyperprolactinaemia: experience with 4,199 prolactin assays and 117 prolactinomas.
    Batrinos ML; Panitsa-Faflia C; Tsiganou E; Pitoulis G; Liapi C
    Int J Fertil Menopausal Stud; 1994; 39(2):120-7. PubMed ID: 8012441
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The characteristics of acromegalic patients with hyperprolactinemia and the differences with hyperprolactinemia patients.
    Huan C; Cui G; Ren Z
    Pak J Pharm Sci; 2015 Mar; 28(2 Suppl):713-8. PubMed ID: 25796163
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Transsphenoidal pituitary resection for preoperative diagnosis of prolactin-secreting pituitary adenoma in women: long term follow-up.
    Feigenbaum SL; Downey DE; Wilson CB; Jaffe RB
    J Clin Endocrinol Metab; 1996 May; 81(5):1711-9. PubMed ID: 8626821
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [The amenorrhea-galactorrhea syndrome. Clinical and therapeutic aspects of 5 treated cases].
    Nicoletti I; Filipponi P; Nunzi E; Angeletti G; Santeusanio F
    Minerva Med; 1980 Jan; 71(2):89-96. PubMed ID: 7188809
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Prolactin-producing pituitary adenomas as a cause of primary amenorrhea and their neurosurgical treatment].
    Landolt AM
    Dtsch Med Wochenschr; 1983 Feb; 108(8):298-301. PubMed ID: 6825603
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Amenorrhoea and hyperprolactinaemia (author's transl)].
    Tscherne G
    Wien Klin Wochenschr; 1979 Dec; 91(23):790-3. PubMed ID: 538933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Amenorrhoea, sterility and hyperprolactinaemia. Importance of complex movement tomographic x-ray study and follow-up of the sella turcica.
    L'Hermite M; Hotton F; Kleiner S; Caufriez A; Robyn C
    Ann Endocrinol (Paris); 1977; 38(4):327-32. PubMed ID: 900882
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Hyperprolactinemic disorders.
    Katz E; Adashi EY
    Clin Obstet Gynecol; 1990 Sep; 33(3):622-39. PubMed ID: 2225590
    [No Abstract]   [Full Text] [Related]  

  • 58. Transsphenoidal adenomectomy for GH-, PRL- and ACTH-secreting pituitary tumours: outcome analysis in a series of 125 patients.
    Esposito V; Santoro A; Minniti G; Salvati M; Innocenzi G; Lanzetta G; Cantore G
    Neurol Sci; 2004 Dec; 25(5):251-6. PubMed ID: 15624082
    [TBL] [Abstract][Full Text] [Related]  

  • 59. [Alteration of prolactin secretion after transsphenoidal adenomectomy for prolactinomas].
    Yokoyama M
    No To Shinkei; 1990 Aug; 42(8):773-9. PubMed ID: 2223270
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Recurrence of hyperprolactinaemia following discontinuation of dopamine agonist therapy in patients with prolactinoma occurs commonly especially in macroprolactinoma.
    Barber TM; Kenkre J; Garnett C; Scott RV; Byrne JV; Wass JA
    Clin Endocrinol (Oxf); 2011 Dec; 75(6):819-24. PubMed ID: 21645021
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.